Genetics and Genomics
- Genetic Foundations of Diabetes
- Genomic Tools in Endocrine Disorders
- Genetic Epidemiology and Diabetes: Insights into Population-Based Studies
- Genomics and Precision Medicine for Obesity and Metabolic Syndrome
- Ethical and Clinical Challenges in Genomic Medicine for Endocrinology
- Emerging Technologies and Genomic Medicine in Diabetes Care
Diabetes is a complex, multifactorial disease characterized by chronic hyperglycemia due to impaired insulin secretion, insulin resistance, or both. It manifests primarily in two forms: Type 1 Diabetes (T1D) and Type 2 Diabetes (T2D), each with distinct genetic and environmental contributions. Advances in genetics and genomics have provided crucial insights into the molecular mechanisms underlying diabetes, enhancing our understanding of its pathophysiology and paving the way for personalized medicine. T1D is an autoimmune disorder where the immune system attacks insulin-producing beta cells in the pancreas. Genome-wide association studies (GWAS) have identified over 50 genetic loci associated with T1D, including the HLA (Human Leukocyte Antigen) region, which plays a significant role in immune regulation. Specific HLA alleles, such as HLA-DR3 and HLA-DR4, significantly increase the risk of T1D. Meanwhile, other genes like INS (insulin), PTPN22, and CTLA4 contribute to the autoimmune response, underscoring the importance of immune-related pathways in T1D pathogenesis.
In contrast, T2D is a metabolic disorder influenced by a complex interplay of genetic and lifestyle factors, including obesity, physical inactivity, and dietary habits. Genomic studies have identified over 400 genetic variants linked to T2D, many of which are involved in glucose metabolism, insulin secretion, and beta-cell function. Notable genes include TCF7L2, which influences insulin secretion, and FTO, which is associated with obesity and insulin resistance. Polygenic risk scores, derived from aggregating the effects of these variants, have shown potential in predicting T2D risk and tailoring preventive strategies. Beyond single-gene analyses, epigenetics and transcriptomics are revealing how environmental factors modulate gene expression through mechanisms like DNA methylation and histone modifications, contributing to diabetes onset and progression. The integration of multi-omics data, including proteomics and metabolomics, is further enriching our understanding of diabetes heterogeneity, leading to more precise classifications and targeted interventions. Thus, the genetics and genomics of diabetes represent a rapidly evolving field, promising transformative advancements in diagnosis, prevention, and treatment.
